Search Results

Stem Cell Transplant: Who Can Benefit and Who Can Be the Donor?
Blog

Stem Cell Transplant: Who Can Benefit and Who Can Be the Donor?

A stem cell transplant is a treatment that involves infusing hematopoietic (blood-forming) stem cells from a donor into a recipient. The collection of infused stem cells is called the stem cell “graft.”

Lyme Disease

Lyme disease is spread to humans through the bite of infected ticks. Symptoms of Lyme disease include fever, swollen lymph nodes, headache, stiff neck, tiredness, swelling of large joints and red rash that often has a “bulls-eye” appearance.

Article

Stem Cell Transplant: HLA Typing

Learn how HLA typing is done.

Article

Resources

Learn more about the resources offered by the Biopathology Center at Nationwide Children's Hospital.

News

Biospecimen Core Resource Wins NIH Contract to Further Cancer Research

The Biospecimen Core Resource (BCR) in The Research Institute at Nationwide Children’s Hospital has received a new $4.5 million federal contract — with the potential of reaching more than $49.9 million over five years — to accept, process, ensure quality, and distribute tumor

Article

Fellow Accomplishments

Find the citations for our Infectious Disease Fellows' abstracts, presentations and awards. 

Article

Research Grants

See the latest grants awarded to the researchers at the Center for Injury Research and Policy.

Article

Rapid Genome Sequencing

Your child’s doctor has recommended a genetic test called rapid genome sequencing (rGS). This test looks for changes in DNA that could cause or contribute to a medical condition. About Your Genetics Our bodies are made up of billions of building blocks called cells. Each cell contains DNA.

Central Ohio Poison Center
Specialty

Central Ohio Poison Center

The Central Ohio Poison Center provides central and southeastern Ohio residents with state-of-the-art poison prevention, assessment and treatment.

SMA Clinical Trial Provides Hope for Families
Blog

SMA Clinical Trial Provides Hope for Families

Tragically, most children with Type I Spinal Muscular Atrophy (SMA1) don’t live past their 2nd birthday. I believe the answer for these patients and their families is gene therapy.

Most Popular Pages
Specialty

Asthma Program

Specialty

Clinical Therapies

Condition

Headaches

Condition

Nasal Congestion